Our Team

We have built an organisation that attracts people of only the highest calibre, with great experience and expertise.


Vegard Nilsen


Espen Nordhus

Executive Chairman

Portfolio Managers

Andrea Cavalleri

CIO (Life)

Herbie Lloyd

CIO (Non-Life)

Philippe Shaw-Jackson

Portfolio Manager

Raphael Rayees

Portfolio Manager (Traded)


Paul Larrett

Chief Underwriting Officer

Richard Godfrey

Deputy Underwriting Officer & Portfolio Manager (Traded)

Global Investor Relations

Yuko Hoshino

Co-head of Global Investor Relations

Weston Tompkins

Co-head of Global Investor Relations

Patrick Witteveen

Head of Investor Relations & Business Development Europe

Cate Kenworthy

Head of Investor Relations & Business Development UK

Global Origination

Cahal Doris

Senior Originator (Non-Life)

George Mawdsley

Senior Originator (Non-Life)

Simon Arnott

Head of Business Development – Non-Life

Luca Tres

Head of Life

Tim Radford

Life Origination & Structuring

Antonio Pombeiro

Life Origination and Structuring


Paul McCabe


Risk Management

Stephen Lister


Value Proposition in Non-Life and Life Origination:


  • Breadth of origination capabilities across insurance, reinsurance and retrocession.
  • Key relationships with brokers and cedents at all levels of the organisations.
  • Proprietary view of risk.
  • No close links to any insurance companies.


  • Dedicated in-house Life actuarial, structuring and legal team.
  • Proactive origination approach that leverages a broad network of existing contacts within the insurance, reinsurance, consultancy and banking world.
  • 12-year track-record of completing bespoke, privately negotiated transactions.
  • Our team focusses on sourcing life ILS transactions with ‘pure’ biometric risks, not moving into non-core areas that would lower the decorrelation of our offering.


Operational Excellence – a Sustainable Competitive Advantage

  • Institutional quality platform.
  • Robust in-house operational team and infrastructure alongside rigorous analysis of potential investments and supported by extensive actuarial modelling capabilities.
  • Comprehensive compliance framework.